A Vertebrate Aldo-keto Reductase Active with Retinoids and Ethanol*

Bernat CrosasDagger §, Ella Cederlund§, Dámaso TorresDagger , Hans Jörnvall§, Jaume FarrésDagger , and Xavier ParésDagger

From the Dagger  Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain and the § Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-17177 Stockholm, Sweden

Received for publication, November 20, 2000, and in revised form, January 9, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Enzymes of the short chain and medium chain dehydrogenase/reductase families have been demonstrated to participate in the oxidoreduction of ethanol and retinoids. Mammals and amphibians contain, in the upper digestive tract mucosa, alcohol dehydrogenases of the medium chain dehydrogenase/reductase family, active with ethanol and retinol. In the present work, we searched for a similar enzyme in an avian species (Gallus domesticus). We found that chicken does not contain the homologous enzyme from the medium chain dehydrogenase/reductase family but an oxidoreductase from the aldo-keto reductase family, with retinal reductase and alcohol dehydrogenase activities. The amino acid sequence shows 66-69% residue identity with the aldose reductase and aldose reductase-like enzymes. Chicken aldo-keto reductase is a monomer of Mr 36,000 expressed in eye, tongue, and esophagus. The enzyme can oxidize aliphatic alcohols, such as ethanol, and it is very efficient in all-trans- and 9-cis-retinal reduction (kcat/Km = 5,300 and 32,000 mM-1·min-1, respectively). This finding represents the inclusion of the aldo-keto reductase family, with the (alpha /beta )8 barrel structure, into the scenario of retinoid metabolism and, therefore, of the regulation of vertebrate development and tissue differentiation.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Short chain dehydrogenases/reductases (SDR),1 medium chain dehydrogenases/reductases (MDR), and aldo-keto reductases (AKR) are three oxidoreductase superfamilies that catalyze the oxidation and reduction of a broad range of alcohol and aldehyde compounds of physiological or pharmacological significance (1-3).

In MDR, the alcohol dehydrogenase (ADH) family constitutes a complex system grouped into several classes (4, 5). ADH1 is the classical enzyme responsible for liver ethanol metabolism, which also exhibits activity with retinoids (6, 7). ADH2 is a liver enzyme that may marginally contribute to ethanol and retinoid metabolisms (8, 9). ADH3 is a glutathione-dependent formaldehyde dehydrogenase (FALDH) inactive with retinoids (6). ADH4 exhibits a unique epithelial distribution and is abundant in the upper gastrointestinal tract mucosa and eye (10-12). It is very efficient with retinoids rather than with ethanol, and it has been proposed to have a role in retinoic acid synthesis (6, 13-15). ADH7 has been described only in chicken embryo, exhibiting activity with retinoids (16). ADH8 is an NADP(H)-dependent form with tissue distribution and substrate specificity similar to those of mammalian ADH4, which has been described in amphibians (17).

The SDR superfamily contains an alcohol dehydrogenase that accounts for ethanol metabolism in Drosophila (18) and several mammalian forms that exhibit activity with retinoids (15, 19, 20). Within the AKR superfamily, several groups of enzymes with related structure and function have been established (3). Among them, the aldose reductase (AR), aldehyde reductase, and hydroxysteroid dehydrogenase (HSD) families have been profoundly characterized in mammals. The AR family has been suggested to be involved in the development of secondary diabetic complications (21) because of its ability to reduce glucose to sorbitol (22), a hyperosmotic compound. Other roles in aldehyde detoxification, osmotic homeostasis, steroid conversion, and catecholamine metabolism have been also proposed for AR (23-26).

Several forms including human ARL1 (aldose reductase-like 1) (27), small intestine reductase (28), mouse vas deferens reductase (29), mouse fibroblast growth factor-regulated protein (30), and Chinese hamster ovary reductase (31) have been described as a distinct group (3) sharing 70% amino acid identity with AR sequences.

Vitamin A or retinol (ROL) is the precursor of retinal (RAL) and of retinoic acid (RA). RAL is necessary for vision, and RA is essential for growth, development, and cellular functions (32, 33). Biosynthesis of RA from vitamin A implies reversible oxidation of ROL to RAL and irreversible oxidation of RAL to RA. The latter compound, in the all-trans- and 9-cis-isomeric forms, exerts its regulatory function bound to nuclear receptors (34). In photoreceptor cells, 11-cis-RAL binds to opsin to form rhodopsin. When one photon is absorbed by rhodopsin, 11-cis-RAL is isomerized to all-trans-RAL, which dissociates from opsin. In all-trans-RA and 9-cis-RA synthesis from ROL, and in rhodopsin regeneration, several oxidoreduction steps occur, which are catalyzed by MDR and/or SDR enzymes, important for the regulation of these processes (15, 20). No activity with retinoids has been ever reported in enzymes from any AKR group.

In this study we have recognized an activity in the upper digestive tract of chicken, similar to that of ADH from the MDR family previously identified in mammals (11, 35) and amphibians (17). However, this avian enzyme was not an ADH of the MDR family, but, surprisingly, an AKR. Thus, we have here characterized the first member of the AKR superfamily with NADP(H)-dependent retinal reductase and ethanol dehydrogenase activities.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Avian Tissues-- Chicken (Gallus domesticus) tissues were obtained immediately after death from a local slaughterhouse. The tissues were cut, cleaned, rinsed in ice-cold distilled water, frozen in liquid nitrogen, and stored at -80 °C. For enzyme analysis, tissues were thawed, fragmented, and homogenized in 10 mM Tris-HCl, 2 mM dithiothreitol, pH 7.6 (1:1 w/v).

Enzyme Purification-- Tissue samples (tongue and esophagus, 390 g) were pooled and homogenized in 10 mM sodium phosphate, 2 mM dithiothreitol, pH 7.0. The homogenate was centrifuged (27,000 × g, 30 min, 4 °C), filtered through glass wool, ultracentrifuged (85,000 × g, 30 min, 4 °C), and filtered again. The supernatant was dialyzed against the initial buffer and applied to a CM-Sepharose (Amersham Pharmacia Biotech) column (2.5 × 40 cm) equilibrated with the same buffer. The column was washed with 400 ml of buffer followed by a linear gradient (500 ml) of increasing NaCl concentration (0-250 mM). The fractions exhibiting octanol dehydrogenase activity were pooled and concentrated with an Amicon concentrator (Diaflo PM10 membranes). The preparation was dialyzed against the initial buffer and applied to a 2',5'-ADP-agarose (Amersham Pharmacia Biotech) column (1 × 20 cm). The column was washed with the same buffer, and the active fractions were pooled, concentrated, dialyzed against 10 mM Tris-HCl, 2 mM dithiothreitol, pH 8.2, and applied to an HPLC system (Waters 600) equipped with a Q column. Elution of the enzyme was performed with a linear gradient of sodium acetate (0-300 mM). The active fractions were dialyzed against 10 mM Tris-HCl, 2 mM dithiothreitol, pH 8.2, and applied to a fast protein liquid chromatography (Amersham Pharmacia Biotech) equipped with a Sephacryl-S200HR column. Protein concentrations were determined by the Bio-Rad protein assay method, using bovine serum albumin as a standard. Homogeneity was assessed by electrophoresis on SDS-polyacrylamide gel (36) and the silver stain technique.

Starch Gel Electrophoresis-- Electrophoresis on starch gel was performed as described (11), except that the gel buffer contained 0.74 mM NADP instead of NAD. Gel slices were activity stained with 1 M ethanol or 0.1 M 2-buten-1-ol and 0.1 mM NADP.

Mass Spectrometry-- Matrix-assisted laser desorption ionization time-of-flight mass spectra were acquired on a Bruker Biflex spectrometer equipped with a pulsed nitrogen laser (337 nm) in linear positive ion mode and using a 19 kV acceleration voltage. Samples were prepared by mixing equal volumes of a saturated solution of the matrix in 0.1% trifluoroacetic acid in water/acetonitrile, 2:1, and a protein solution at a concentration range of 1-10 µM. From this mixture, 1 µl was spotted on the sample slide and allowed to evaporate to dryness. Mass spectra were calibrated externally using appropriate protein standards.

Protein Sequence Analysis-- Protein for sequence analysis was reduced with dithiothreitol and carboxymethylated with iodoacetate as described for ADH (17). Aliquots were then submitted to proteolytic digestions with trypsin, Lys-C protease, N-Asp protease, or Glu-C protease in 0.1 M ammonium bicarbonate or to treatment with CNBr in 70% formic acid. Peptide mixtures were purified by reverse phase HPLC on C18 columns with a gradient of acetonitrile in 0.1% aqueous trifluoroacetic acid. Fractions obtained were submitted to analysis in an ABI Procise HT sequencer, after prescreening in a Voyager DEPRO matrix-assisted laser desorption ionization time-of-flight mass spectrometer to secure finding relevant fragments for sequence analysis. Several peptides were also submitted to collision-induced dissociation sequence analysis with a Micromass quadrupole time-of-flight tandem mass spectrometer equipped with a nano-ES ionization inlet.2

cDNA Cloning and Sequence Analysis-- Poly(A)+ RNA was isolated from chicken tongue and esophagus with the Quickprep® Micro mRNA Purification Kit (Amersham Pharmacia Biotech). The first strand of the cDNA was synthesized from 2 µg of RNA poly(A)+ with You-Prime first strand beads (Amersham Pharmacia Biotech) using a T17 primer or the R0R1-(dT)17 primer adaptor (37). The resulting pools of cDNA were used as templates in a polymerase chain reaction with CHICK1 (5'-ATGCCIGTIYTIGGIYTIGGIACITGG-3', amino acid positions 16-24) and CHICK2 (5'-TGIGGIACIGGDATIGCICKCCART-3', amino acid positions 302-310), designed from peptide sequences.

To obtain the 5' and 3' cDNA ends, the rapid amplification of cDNA ends method (37) was followed. For the amplification of poly(A) end, CHICK3 (5'-AGGTTCTGATCCGGTTC-3', amino acid positions 244-249), CHICK4 (5'-GACTTCGAGCTGTCTAA-3', amino acid positions 285-290) specific primers, and R0 (5'-AAGGATCCGTCGACATC-3') and R1 (5'-GACATCGATAATACGAC-3'), corresponding to the primer-adaptor sequence, were used in two nested PCR.

To obtain the 5' end, the first strand of cDNA was synthesized using a sequence-specific oligonucleotide primer (CHICK5, 5'-AAGTTTGAGATTCCAATGG-3', amino acid positions 162-168) with AMV reverse transcriptase (Roche Molecular Biochemicals), at 42 °C. A poly(A) tail was added to the cDNA pool with deoxynucleotide terminal transferase (Amersham Pharmacia Biotech). The second strand of cDNA was synthesized with the R0R1-(dT)17 primer adaptor and Expand High Fidelity DNA polymerase kit (Roche Molecular Biochemicals). The amplification of 5' end was performed using CHICK6 (5'-ACTTAGTGACAACGAAGAGG-3', amino acid positions 79-84), CHICK7 (5'-CCCAACCCCAACACCGGCAT-3', amino acid positions 19-25), R0 and R1 primers, in two nested PCR.

PCR amplifications were performed with the Expand High Fidelity kit (Roche Molecular Biochemicals). The PCR products were directly sequenced or phosphorylated with T4 polynucleotide kinase (Roche Molecular Biochemicals), cloned into the SmaI site of pBluescript II SK(+), and sequenced (AlfExpress, Amersham Pharmacia Biotech).

Northern Blot Hybridization-- Total RNA was isolated from frozen tissues by the guanidinium thiocyanate method (38). RNA-poly(A)+ was isolated from 20-µg aliquots of total RNA with the Quickprep® Micro mRNA Purification Kit (Amersham Pharmacia Biotech). RNA samples were run in 1× MOPS, 2.2 M formaldehyde, 1% agarose gel and transferred onto Nylon membranes (Schleicher & Schuell) by means of a TurboblotterTM (Schleicher & Schuell). RNA was immobilized by a 20-s pulse of UV light in a Stratalinker (Stratagene). A 870-bp chicken AKR DNA-specific probe (50 ng) was labeled with 50 µCi of [alpha -32P]dCTP (3000 Ci/mmol, Amersham Pharmacia Biotech) by the random priming method (Prime-a-Gene labeling system, Promega). Membrane prehybridization and hybridization were performed in 0.2 M sodium phosphate, 1 mM EDTA, 1% bovine serum albumin, 1% SDS, pH 7.2, at 65 °C, overnight. Membranes were washed in 40 mM sodium phosphate, 1 mM EDTA, 1% SDS, pH 7.2, at 65 °C, for 1 h and exposed to Hyperfilm-MP (Amersham Pharmacia Biotech) overnight at -80 °C with two intensifying screens.

Enzyme Kinetics-- Activity was determined by monitoring the change in NADPH concentration at 25 °C in a Varian Cary 219 spectrophotometer by measurements at 340 nm, in 0.1 M sodium phosphate, pH 7.5. Glutathione-dependent formaldehyde dehydrogenase activity was measured as reported (39). One unit of activity corresponds to 1 µmol of reduced coenzyme formed or utilized per min, at 25 °C, based on an absorption coefficient of 6220 M-1·cm-1 at 340 nm. Steroids were dissolved in 0.3 M methanol. Methanol was not a substrate nor an inhibitor of chicken AKR under the present conditions (maximum methanol concentration reached in the assay was 45 mM). ROL oxidation and RAL reduction were performed according to a published procedure (40), using reported absorption coefficients (14).

Kinetic parameters were obtained from activity measurements, with substrate concentrations that ranged from at least 0.1× Km to 8× Km. Each individual rate measurement was run in duplicate. Three independent determinations were performed for each kinetic constant. Kinetic constants were calculated using ENZFITTER (Elsevier Biosoft) and expressed as the means ± S.D.

Protein Modeling and Retinoid Docking-- A three-dimensional model of chicken AKR was constructed by adopting its amino acid sequence into the known fold of human AR (Protein Data Bank entry code 1ADS) (41) using the ICM program (version 2.7, Molsoft LLC, 1997), as described (14). The quality of the model was assessed with the PROCHECK program (42).

To study the interaction of retinoids with AKR, the Protein Data Bank coordinates of human AR and the chicken AKR model were used. To prepare human AR structure for docking simulations, hydrogen atoms were added, methyl groups were rotated, and the most severe atomic contacts were minimized. RAL in an extended conformation (carbon chi  angles of single bonds = 180°) was placed into the substrate-binding pocket in the same orientation as the ternary ligand testosterone (43). Nonrigid docking simulations were based upon a Monte Carlo procedure (44), allowing free movement of the substrate, of its rotable bonds, and of the chi  angles of the residues inside a 5 Å radius from the docked substrate. Additional distance restraints were imposed: 1.0-2.4 Å between the aldehyde oxygen of RAL and the catalytic hydroxyl group of Tyr48, and 2.0-2.4 Å between C-15 of RAL and C-4 of NADPH. Similarly, docking simulations with testosterone were performed. Energy values were calculated with the ICM program as reported (14).

Multiple Alignments and Phylogenetic Trees-- Protein and DNA sequences were searched in the GenBank, EMBL, PIR, and SwissProt data bases with the FASTA (45) and BLAST (46) algorithms. The Internet AKR Web page was regularly consulted to update information. Sequence alignments were performed using the GCG program PILEUP. Bootstrap (1000 trials) neighbor-joining phylogenetic trees were calculated by means of the CLUSTALW program (47) and displayed with TREEVIEW program (48).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Enzymatic Forms with ADH Activity in Chicken Tissues-- Several ADH-type bands were detected on starch gel electrophoresis (Fig. 1) because of their NADP(H)-dependent activity staining with 2-buten-1-ol. A putative FALDH (or ADH3) appeared as an anodic band with variable intensity in all tissues analyzed. The nature of this band was assessed by glutathione-dependent activity staining with formaldehyde in duplicate gel slices (not shown). Moreover, a cathodic band detected in liver homogenates could correspond to ADH1 (49). In addition, a previously unidentified anodic band with lower mobility than FALDH appeared in homogenates from eye, tongue and esophagus when 2-buten-1-ol or ethanol was used as a substrate.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Starch gel electrophoresis of chicken tissue homogenates. Activity staining using 2-buten-1-ol as a substrate and NADP as cofactor. T, tongue; H, heart; Ey, eye; B; brain; K, kidney; I, small intestine; Es, esophagus; L, liver; P, purified chicken AKR.

Purification of a Chicken Enzymatic Form with ADH Activity-- The novel enzyme form (later recognized as an AKR) was purified from tongue and esophagus (Table I). In the CM-Sepharose chromatography, an octanol dehydrogenase activity peak was detected in the gradient fractions. In agreement with the results of starch gel electrophoresis, another peak of activity corresponding to FALDH, which overlapped with the major protein peak, was eluted by the initial washing and, therefore, well separated from the novel enzymatic form. The 2',5'-ADP-agarose resin bound weakly the chicken enzyme, which eluted in the washing step, delayed with respect to the major protein peak. The HPLC Q column step resulted in a 2-fold increase in the specific activity, but contaminating proteins remained in the fractions corresponding to the octanol dehydrogenase peak. Finally, the fast protein liquid chromatography purification step with a Sephacryl S200-HR column resulted in a homogeneous enzyme, as demonstrated by SDS-polyacrylamide gel electrophoresis (Fig. 2). The purified preparation showed a specific activity of 0.92 unit/mg with octanol (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of chicken AKR
Activity was measured using 500 µM octanol, 80 µM NADP+ in 0.1 M glycine-NaOH, pH 10.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-polyacrylamide gel electrophoresis of purified chicken AKR. Lane 1, enzyme preparation eluted from the HPLC column. Lane 2, purified enzyme after the fast protein liquid chromatography step.

With the Sephacryl S200-HR column chromatography, a molecular mass of 36.2 kDa was estimated for the native enzyme using a set of proteins as standards. Moreover, molecular mass values of 36 and 36.6 kDa were determined by SDS-polyacrylamide gel electrophoresis (Fig. 2) and mass spectrometry, respectively. Thus, it can be concluded that the native form is a monomer.

cDNA and Protein Sequences of the Novel Enzymatic Form-- Before any data from peptide sequences were available, the first attempt to clone the cDNA was based on degenerated primers deduced from consensus sequences of vertebrate ADH, which were used in the PCR with cDNA from tongue and esophagus. This strategy only produced DNA fragments corresponding to chicken ADH1, which could be marginally expressed in tongue and esophagus, because no active ADH1 was found by starch gel electrophoresis in these tissues (Fig. 1). These preliminary results suggested that no enzyme homologous to mammalian ADH4 or amphibian ADH8 is expressed in the upper digestive tract from chicken.

We therefore decided to investigate the nature of the novel chicken enzyme by protein analysis. However, attempts at direct sequencer degradation gave no result, suggesting that the N terminus was blocked. Therefore, different sets of the carboxymethylated protein were cleaved with proteolytic enzymes. After fractionation with reverse phase HPLC and subsequent sequencer analysis, scans against data banks showed that the peptides obtained were homologs to fragments of AKR enzymes. Hence, the present enzyme was concluded to be a novel type of AKR, with ADH-like activity. Because of the initial failure to get a cDNA sequence with conventional ADH primers, impurities in the protein preparation, and initial unclarities between protein and cDNA data, the protein analysis was continued until essentially the entire amino acid sequence had been determined by sequencer analysis of 57 peptides from five separate digests (with CNBr, trypsin, N-Asp, Lys-C, or Glu-C proteases), covering 311 of 316 residues, i.e. all residues except positions 65-69. Finally, the N terminus was proven to be acetylated by collision-induced dissociation analysis in a quadrupole time-of-flight mass spectrometer of the N-terminal fragment from the Glu-C protease digest, which started with acetyl-Ala, by removal of the initiator Met from the primary translation product.2

Using oligonucleotide primers designed according to the peptide sequences, a DNA fragment of 870 bp was obtained by the PCR. The rapid amplification of cDNA ends method generated three additional DNA fragments corresponding to the 5' end (104 and 105 bp) and the 3' end (625 bp). The DNA fragments encompassed a 1504-bp full-length cDNA. It included a 44-bp 5'-flanking region, an open reading frame of 951 bp, encoding a 317-amino acid primary translation product, corresponding to the 316-amino acid acetylated mature form and the initiator Met, and a 509-bp 3'-untranslated region with a poly(A) tail (Fig. 3). The end results of the protein and cDNA data were in complete agreement.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 3.   Nucleotide and amino acid sequences of chicken AKR. Nucleotide numbers are shown above the lettered sequence, and amino acid residue numbers are on the right side. The mature protein starts with acetyl-Ala as shown, after removal of the initiator Met, and the resulting protein sequence contains 316 amino acid residues. A putative polyadenylation signal is underlined at position 1435.

The amino acid sequence of chicken AKR shows high identity with those of the AR (66-69%) and AR-like (68-69%) families (Table II). The N-terminal region of chicken AKR contains one additional amino acid residue with respect to those of AR and AR-like members. However, the amino acid numbering of AR has been used for the novel enzyme. A phylogenetic tree was built by the bootstrap neighbor-joining method using aldo-keto reductase sequences (Fig. 4). An unrooted representation of the tree emphasized four robust clusters constituted by AR, AR-like, HSD, and aldehyde reductase sequences. The chicken AKR positioned below the split of the AR and AR-like clusters.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Alignment of amino acid residues constituting the substrate-binding pocket and A, B, and C loops (63) of different AKR enzymes
In bold type and underlined, amino acid residues that correspond to important positions in the substrate-binding pocket. In bold type, amino acid residues identical to those of chicken AKR sequence. In gray, amino acid residues that differ from those of chicken AKR sequence. The amino acid numbering of AR family is used. Protein sequences were taken from data banks, and the alignment was performed using the GCG program PILEUP.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   Phylogenetic tree of AKR superfamily. AR, AR-like, aldehyde reductase, HSD, and related sequences are included. Sequences were obtained from data banks. Branch lengths are proportional to the number of residue substitutions. Bootstrap values higher than 950 (over 1000 trials) are indicated as a percentage. *, bootstrap value of 644.

The novel enzyme contains the catalytic tetrad (Asp43, Tyr48, Lys77, and His110) characteristic of other AKR forms (50), and the residues strictly (Asn160, Gln183, and Ser263) and highly conserved (Ser159, Tyr209, Leu212, Lys262, Arg268, Glu271, and Asn272) involved in NADP(H) binding (3). In contrast to the conserved nature of the coenzyme-binding site, the residues considered important for substrate specificity differ notably between chicken AKR and AR or AR-like sequences (Table II) (see below).

Northern Blot Analysis-- Chicken AKR mRNA (1.8 and 4.0 kilobases) was found in the eye and the upper digestive tract (tongue and esophagus) but not in small intestine (Fig. 5). The 1.8-kilobase transcript is likely to represent the mature mRNA. No signal was detected in brain, skeletal muscle, heart, or liver (not shown). These results are consistent with those obtained by starch gel electrophoresis and activity staining (Fig. 1), which also detected active enzyme in eye, tongue, and esophagus, indicating a tissue-specific expression of the chicken AKR gene.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 5.   Northern blot analysis of chicken AKR. Membrane was prepared with poly(A)+ RNA (2 µg/lane). T, tongue; Es, esophagus; I, small intestine; Ey, eye.

Substrate Specificity of Chicken AKR-- Kinetic constants of chicken AKR were determined with several substrates (Tables III and IV). Chicken AKR exhibited a marked NADP(H) preference, suggesting carbonyl reduction as the most likely physiological reaction (Table III). Compounds such as D,L-glyceraldehyde and glyoxal, characteristic substrates for the aldo-keto reductases, were relatively poor substrates for chicken AKR. Moreover, no activity was found with aldose sugars (glucose, galactose, ribose, and xylose) at concentrations up to 150 mM or with steroids (corticosterone, epiandrosterone, dehydroisoandrosterone, 5alpha -androstane-17beta -ol-3-one, and 5-cholesten-3alpha -ol-7-one) at concentrations up to 150 µM. 3-Nitrobenzaldehyde was a very good substrate, exhibiting the lowest Km and the highest catalytic efficiency among the compounds tested. Aliphatic aldehydes such as hexanal and 2-trans-hexenal were actively used by chicken AKR, with no significant differences between the two isomers.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Kinetic constants of chicken AKR with aldehydes, alcohols, and cofactors
All determinations were performed in 33 mM sodium phosphate, pH 7.5, with 100 µM NADP or 80 µM NADPH, except for coenzyme constants.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Kinetic constants of chicken AKR with retinoids
Determinations were performed with 100 µM NADP or 80 µM NADPH, in 33 mM sodium phosphate, 0.02% Tween 80, pH 7.5. N.A., no activity.

An interesting property of chicken AKR is its ADH activity, because no data on aliphatic alcohols as substrates for AKR enzymes are found in the literature. All aliphatic alcohols assayed were substrates that saturated the enzyme. The Km values decreased steadily as the number of carbons in the aliphatic chain increased, whereas only a small variation was detected in kcat values (Table III).

Among the results obtained with different substrates, the most striking are those concerning retinoids (Table IV), because the AKR superfamily has not been reported before to be active with these physiological compounds. Chicken AKR has the ability to reduce all-trans-, 9-cis-, and 13-cis-RAL isomers and to oxidize all-trans- and 9-cis-ROL. Km values are similar for all the RAL isomers, but kcat values differ notably. The best substrate was 9-cis-RAL with a kcat value 5- and 20-fold higher than those for all-trans-RAL and for 13-cis-RAL, respectively, and with an extremely high kcat/Km ratio (32000 mM-1·min-1). Again, 9-cis-ROL was the best retinoid substrate for the oxidation reaction. No differences were found in the Km values of all-trans-ROL and 9-cis-ROL with respect to their corresponding aldehydes. In contrast, the kcat values were much lower for the alcohols (Table IV).

Molecular Model of Chicken AKR-- A molecular model of the chicken AKR tertiary structure was built (Fig. 6A). Following amino acid identity (Table II) and phylogenetic criteria (Fig. 4), the structures of the AR and AR-like enzymes were considered the most valid templates. The coordinates of human AR (41), mouse fibroblast growth factor-regulated protein (51), and Chinese hamster ovary reductase (52) three-dimensional structures were used, but no significant differences were found between the three calculated models for chicken AKR (the root mean square deviation was 0.9-1 Å), and thus the one obtained from the human AR template was used as a working object.


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 6.   Homology-based model and docking simulations of chicken AKR. A, ribbon representation of the protein structure with bound NADPH (green) and all-trans-RAL (red). The residues at loops A, B, and C conserved in AR sequences and substituted in chicken AKR are represented as orange spheres (positions 47, 111, 113, 122, 124, 129, 130, 216, 223, 224, 291, 298-300, 302, 303, and 312). B and C, accessible surface of the residues in the substrate-binding pocket (yellow) of the chicken AKR model (B) and crystal structure of human AR (41) (C). D and E, All-trans-RAL (red) bound to the model of active site of chicken AKR (D) and human AR (E). The atomic distances (Å) between groups involved in the catalytic reaction (between the O of the aldehyde group and the hydroxyl of Tyr48 and the Nepsilon of His110 and between the C of the aldehyde and the C4 of the nicotinamide ring) are indicated.

The model shows that the residues responsible for the NADP(H) over NAD(H) preference, i.e. Lys262 and Arg268, are conserved in chicken AKR. However, an Asp residue is found at position 264, which is never occupied by residues with acidic side chains in other members of the family. In the crystallographically determined structure, the main chain nitrogen at position 264 faces the 2'-phosphate of NADP(H) and establishes a hydrogen bond with the coenzyme (41). Our model shows that the distance between the charged group of Asp264 in chicken AKR and the NADP(H) 2'-phosphate is 4.1 Å and, therefore, a negligible effect on cofactor binding in terms of electrostatic energy should be expected.

The substrate-binding pocket of the chicken AKR model is highly hydrophobic. It includes mostly aromatic (Trp20, Phe47, Tyr48, Trp79, Tyr111, Tyr209, and Trp219) and aliphatic (Ala45, Leu121, Leu122, and Ile298) residues. At the edge of the active site, position 47, typically occupied by apolar aliphatic residues, and position 111, with a conserved Trp in AR, are considered responsible for the sugar and steroid specificity (3, 53). Significantly, chicken AKR, inactive with pentose or hexose sugars and steroids, contains aromatic and bulky residues at these positions, Phe47 and Tyr111 (Table II). The absence of Cys residues at positions 298 and 303 could also contribute to the kinetic properties of chicken AKR with glyceraldehyde and aldosugars. Thus, human AR C298S and C303S mutants show a decrease in catalytic efficiency with glucose and xylose, and the C298S mutant shows an increased Km with glyceraldehyde (54).

The presence of Leu121 and Leu122, in loop A and Ile298, Pro299, Val300, Pro301, Gln302, and Ser303 in loop C (Table II), in addition to the Phe47 and Tyr111 substitutions, confer a distinct geometry to the substrate-binding cleft with respect to human AR (Fig. 6, B and C) that could be correlated with the substrate specificity of chicken AKR. The cleft of the chicken enzyme is structured as a funnel shaped cavity that is suitable for binding hydrophobic substrates containing the carbonyl reactive group at the end of an aliphatic chain, such as retinoids, but unsuitable for bulky polycyclic compounds, such as steroids (Fig. 6B). In contrast, the structure of human AR active site (Fig. 6C) is appropriate for steroid binding as well as for retinoids (see below).

Docking Simulations-- The interaction of RAL with chicken AKR was studied by docking simulations in our three-dimensional model. The molecule of all-trans-RAL fitted the substrate-binding pocket, and many features suggest that this interaction may correspond to a productive complex. The position of the RAL molecule in the substrate-binding pocket was found to be such that the re face of the aldehyde group is parallel to the nicotinamide ring (23, 53). The RAL aliphatic chain does not clash against any of the voluminous side chains that line the cavity, and the beta -ionone ring of the retinoid showed complementarities with residues from loops A and C. The atomic distances between the oxygen of the aldehyde group and the hydroxyl group of Tyr48, and the Nepsilon of His110 (catalytic residues) in the model were 1.8 and 3 Å, respectively. The atomic distance between the C4 of the nicotinamide ring and the C15 of RAL was 2.2 Å (Fig. 6D). The angles drawn by lines through nicotinamide C4-nicotinamide H4R-RAL C15 and the nicotinamide H4R-RAL C15-RAL oxigen were 150° and 100°, respectively. Moreover, 9-cis-RAL also bound to the substrate-binding pocket of chicken AKR with distances to catalytic residues similar to those of the all-trans isomer (not shown). These distances and angles in the model are compatible with those determined for a transition state (50, 55). All-trans-RAL also could be docked to the substrate-binding pocket of the crystal structure of human AR. Although this molecule adopted a different orientation to the one observed in chicken AKR, the distances of the carbonyl group of all-trans-RAL to the catalytic residues and NADPH predict a productive binding (Fig. 6E).

The absence of activity of chicken AKR with steroids was studied by docking simulations with testosterone (not shown). The substrate-binding pocket could harbor the testosterone molecule; however, unfavourable contacts were found with Phe47 (Fig. 6B), the side chain of which was sandwiched between the protein main chain and the steroid. Interestingly, these contacts disappeared in the docking simulation when Phe was substituted by Val, the residue found in human AR at position 47.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

An alcohol dehydrogenase, named ADH4, active with ethanol and retinoids and present in the eye and digestive tract organs has been described in mammals (6, 11, 56, 57). In the stomach of amphibians, an alcohol dehydrogenase with similar substrate specificity, but a separate origin has been reported (ADH8) (17). Interestingly, ADH8 exhibits a NADP(H) preference over NAD(H), a feature unique to this ADH in the MDR superfamily from animals. We, therefore, searched for a similar enzyme, either NAD(H) or NADP(H)-dependent, in an avian species, G. domesticus. An NADP(H)-dependent enzyme, active with ethanol and retinoids, was found in digestive organs and in the eye of chicken. But, unexpectedly, it does not correspond to an ADH of the MDR superfamily but to a completely different enzyme, a reductase of the AKR superfamily. We have characterized this chicken AKR enzyme and showed that it exhibits distinct structural and functional properties.

Chicken AKR showed a Km value of 6 mM with D,L-glyceraldehyde, 100-300-fold higher than that reported for human AR with this substrate (20-70 µM) (22, 54, 58) but similar to the values exhibited by human AR-like and Chinese hamster ovary enzymes (2 and 28 mM, respectively) (27, 31). An important feature of chicken AKR is the absence of activity with glucose, whereas AR enzymes are typically active with this compound (22, 25). In contrast, with the exception of human AR-like enzyme (27), AR-like forms are inefficient (59) or not active at all (25, 31) with glucose.

Chicken AKR is not active with steroids containing hydroxyl or ketone groups in their 3alpha , 17beta , or 20alpha positions. In contrast, many AKR enzymes, such as HSDs, human AR, Chinese hamster ovary reductase, and mouse vas deferens reductase, catalyze steroid conversion (3, 22, 25, 31, 59), although the human AR-like enzyme is not active with progesterone nor with 17alpha -hydroxyprogesterone (27). Therefore, in relation to the kinetic properties with both sugars and steroids, chicken AKR exhibits more similarities with the AR-like than with the AR enzymes.

Chicken AKR is active with aliphatic aldehydes and the corresponding alcohols, including ethanol. To our knowledge, activity with ethanol has never been reported for any member of the AKR family. The higher hydrophobicity of the substrate-binding site of chicken AKR, as compared with other enzymes of the family, is probably at the basis of its distinct specificity. The localization of avian AKR in upper digestive tract tissues suggests a possible contribution as a metabolic barrier against aliphatic alcohols and aldehydes present in the food stuffs. This role was previously proposed for mammalian ADH4, also expressed in these tissues, and with similar kinetic constants toward aliphatic substrates (6, 11).

Another unexpected feature is that chicken AKR can transform retinoids with high catalytic efficiency. The kcat/Km values of chicken AKR with all-trans-RAL and 9-cis-RAL are similar to those for human AR with its best physiological substrates (22, 23), and they support a physiological role of chicken AKR in RAL reduction. Chicken AKR is the fastest 9-cis-RAL reductase known. Its kcat (860 min-1) is several times higher than those for the best MDR ADHs (7, 13, 14, 17), which are faster enzymes than the SDR RAL reductases (15). The kcat/Km (catalytic efficiency) is also extremely high for 9-cis-RAL (32000 mM-1·min-1), only comparable with the value of amphibian ADH8 with all-trans-RAL (33750 mM-1·min-1) (17). Moreover, the catalytic efficiency of chicken AKR for all-trans-RAL is similar to that of the most efficient ADHs (7, 13, 14, 17). In conclusion, the present AKR kinetic constants, mostly kcat and kcat/Km, are similar or even higher than those of the SDR and MDR enzymes active with retinoids, further supporting a role of chicken AKR in RAL reduction.

In the light of these results, it seems reasonable to propose a new and critical biological function for the AKR superfamily, the metabolism of retinoids. Chicken AKR, like mammalian ADH4, may perform two different roles in regard to retinoid metabolism: 1) regeneration of rhodopsin and involvement in the homeostasis of RAL through the reduction of all-trans-RAL to all-trans-ROL in the eye tissues and 2) conversion of retinoids and the regulation of RA synthesis, essential in tissue differentiation and maintenance in ocular and digestive tract tissues.

The upper digestive tract and the eye of vertebrates need an oxidoreductase capable of metabolizing ROL and RAL. In mammals, an NAD(H)-dependent ADH (ADH4) of the MDR family seems to participate in this function. In amphibians, an NADP(H)-dependent ADH (ADH8), also of the MDR family, accounts for this activity. In the present avian line, a different structure, an NADP(H)-dependent aldo-keto reductase, is used for this function. It is relevant to consider that this specificity toward retinoids may be also present in previously well characterized AKR members from other vertebrate groups, including human. In agreement to this, our docking simulations of the crystallographically determined human AR structure with retinoids suggest a productive binding of these compounds.

Activity-wise, SDR, MDR, and AKR superfamilies have evolved convergently, although they structurally exhibit divergence with distant relationships (3, 60). In SDR and MDR, the convergence has given rise to paradigmatic cases in the metabolisms of ethanol and retinoids. Thus, the widespread MDR ADH is the one responsible for ethanol metabolism in vertebrates, yeast, and bacteria. However, in Drosophila, which lacks an MDR ADH, an SDR ADH exerts that function (61). Moreover, several forms of SDR and MDR are ROL dehydrogenases or RAL reductases, apparently involved in physiological retinoid metabolism (15, 20). We have shown here that AKR has also evolved convergently with SDR and MDR in terms of ethanol and ROL metabolism. The (alpha /beta )8 barrel of the AKR tertiary structure, with a conserved core and variable loops in outer domains, responsible for substrate binding, represents a highly adaptable scaffold, able to evolve and develop distinct functions (62) as the retinoid oxidoreduction, here demonstrated. The inclusion of the AKR superfamily in the metabolism of retinoids defines a new scenario where the triad SDR-MDR-AKR would participate in the cellular regulation of the essential signaling function of retinoids.

    Note Added in Proof

Chicken AKR has been designed AKR1B12 based on cluster analysis including members of the AKR superfamily, as recommended by Jez et al. (Jez, J. M., Flynn, T. G., and Penning, T. M. (1997) Biochem. Pharmacol. 54, 639-647).

    FOOTNOTES

* This work was supported by Commission of the European Union Grant BIO4-CT97-2123, Spanish Dirección General de Enseñanza Superior e Investigación Científica Grants PM96-0069 and PB98-0855, and Swedish Medical Research Council Project 13X-3532.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ295030.

To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain. Tel.: 34-93-5813026; Fax: 34-93-5811264; E-mail: xavier.pares@uab.es.

Published, JBC Papers in Press, February 7, 2001, DOI 10.1074/jbc.M010478200

2 D. Hirschberg, E. Cederlund, A. P. Jonsson, B. Crosas, J. Farrés, X. Parés, T. Bergman, and H. Jörnvall, in preparation.

    ABBREVIATIONS

The abbreviations used are: SDR, short chain dehydrogenase/reductase; ADH, alcohol dehydrogenase; AKR, aldo-keto reductase; AR, aldose reductase; FALDH, glutathione-dependent formaldehyde dehydrogenase; HSD, hydroxysteroid dehydrogenase; MDR, medium chain dehydrogenase/reductase; RA, retinoic acid; RAL, retinal; ROL, retinol; HPLC, high performance liquid chromatography; PCR, polymerase chain reaction; bp, base pair(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Jörnvall, H. (1994) in Toward a Molecular Basis of Alcohol Use and Abuse (Jansson, B. , Jörnvall, H. , Rydberg, U. , Terenius, L. , and Valle, B. L., eds) , pp. 221-229, Birkhäuser, Basel, Switzerland
2. Jörnvall, H., Persson, B., Krook, M., Atrian, S., González-Duarte, R., Jeffery, J., and Ghosh, D. (1995) Biochemistry 34, 6003-6013[Medline] [Order article via Infotrieve]
3. Jez, J. M., Bennett, M. J., Schlegel, B. P., Lewis, M., and Penning, T. M. (1997) Biochem. J. 326, 625-636[Medline] [Order article via Infotrieve]
4. Jörnvall, H., and Höög, J. O. (1995) Alcohol. Alcohol. 30, 153-161[Abstract]
5. Duester, G., Farrés, J., Felder, M. R., Holmes, R. S., Hoog, J. O., Parés, X., Plapp, B. V., Yin, S. J., and Jörnvall, H. (1999) Biochem. Pharmacol. 58, 389-395[CrossRef][Medline] [Order article via Infotrieve]
6. Boleda, M. D., Saubi, N., Farrés, J., and Parés, X. (1993) Arch. Biochem. Biophys. 307, 85-90[CrossRef][Medline] [Order article via Infotrieve]
7. Yang, Z. N., Davis, G. J., Hurley, T. D., Stone, C. L., Li, T. K., and Bosron, W. F. (1994) Alcohol. Clin. Exp. Res. 18, 587-591[Medline] [Order article via Infotrieve]
8. Svensson, S., Stromberg, P., and Höög, J. O. (1999) J. Biol. Chem. 274, 29712-29719[Abstract/Free Full Text]
9. Popescu, G., and Napoli, J. L. (2000) Biochim. Biophys. Acta 1476, 43-52[Medline] [Order article via Infotrieve]
10. Boleda, M. D., Julià, P., Moreno, A., and Parés, X. (1989) Arch. Biochem. Biophys. 274, 74-81[Medline] [Order article via Infotrieve]
11. Moreno, A., and Parés, X. (1991) J. Biol. Chem. 266, 1128-1133[Abstract/Free Full Text]
12. Ang, H. L., Deltour, L., Zgombic-Knight, M., Wagner, M. A., and Duester, G. (1996) Alcohol. Clin. Exp. Res. 20, 1050-1064[Medline] [Order article via Infotrieve]
13. Allali-Hassani, A., Peralba, J. M., Martras, S., Farrés, J., and Parés, X. (1998) FEBS Lett. 426, 362-366[CrossRef][Medline] [Order article via Infotrieve]
14. Crosas, B., Allali-Hassani, A., Martínez, S. E., Martras, S., Persson, B., Jörnvall, H., Parés, X., and Farrés, J. (2000) J. Biol. Chem. 275, 25180-25187[Abstract/Free Full Text]
15. Duester, G. (2000) Eur. J. Biochem. 267, 4315-4524[Abstract/Free Full Text]
16. Kedishvili, N. Y., Gough, W. H., Chernoff, E. A., Hurley, T. D., Stone, C. L., Bowman, K. D., Popov, K. M., Bosron, W. F., and Li, T. K. (1997) J. Biol. Chem. 272, 7494-7500[Abstract/Free Full Text]
17. Peralba, J. M., Cederlund, E., Crosas, B., Moreno, A., Julià, P., Martínez, S. E., Persson, B., Farrés, J., Parés, X., and Jörnvall, H. (1999) J. Biol. Chem. 274, 26021-26026[Abstract/Free Full Text]
18. Schwartz, M. F., and Jörnvall, H. (1976) Eur. J. Biochem. 68, 159-168[Abstract]
19. Simon, A., Hellman, U., Wernstedt, C., and Eriksson, U. (1995) J. Biol. Chem. 270, 1107-1112[Abstract/Free Full Text]
20. Napoli, J. L. (1999) Biochim. Biophys. Acta 1440, 139-162[Medline] [Order article via Infotrieve]
21. Gabbay, K. H. (1975) Annu. Rev. Med. 26, 521-536[CrossRef][Medline] [Order article via Infotrieve]
22. Wermuth, B., Burgisser, H., Bohren, K., and von Wartburg, J. P. (1982) Eur. J. Biochem. 127, 279-284[Abstract]
23. Vander Jagt, D. L., Robinson, B., Taylor, K. K., and Hunsaker, L. A. (1992) J. Biol. Chem. 267, 4364-4369[Abstract/Free Full Text]
24. Grimshaw, C. E. (1992) Biochemistry 31, 10139-10145[Medline] [Order article via Infotrieve]
25. Petrash, J. M., Harter, T. M., and Murdock, G. L. (1996) Adv. Exp. Med. Biol. 414, 465-473
26. Kawamura, M., Eisenhofer, G., Kopin, I. J., Kador, P. F., Lee, Y. S., Tsai, J. Y., Fujisawa, S., Lizak, M. J., Sinz, A., and Sato, S. (1999) Biochem. Pharmacol. 58, 517-524[CrossRef][Medline] [Order article via Infotrieve]
27. Cao, D., Fan, S. T., and Chung, S. S. (1998) J. Biol. Chem. 273, 11429-11435[Abstract/Free Full Text]
28. Hyndman, D. J., and Flynn, T. G. (1998) Biochim. Biophys. Acta 1399, 198-202[Medline] [Order article via Infotrieve]
29. Pailhoux, E. A., Martínez, A., Veyssiere, G. M., and Jean, C. G. (1990) J. Biol. Chem. 265, 19932-19936[Abstract/Free Full Text]
30. Donohue, P. J., Alberts, G. F., Hampton, B. S., and Winkles, J. A. (1994) J. Biol. Chem. 269, 8604-8609[Abstract/Free Full Text]
31. Hyndman, D. J., Takenoshita, R., Vera, N. L., Pang, S. C., and Flynn, T. G. (1997) J. Biol. Chem. 272, 13286-13291[Abstract/Free Full Text]
32. Sporn, M. B., Roberts, A. B., and Goodman, D. S. (1994) The Retinoids: Biology, Chemistry, and Medicine , Raven, New York
33. Nau, H., and Blaner, W. S. (1999) Retinoids: The Biochemichal and Molecular Basis of Vitamin A and Retinoid Action , Springer, Berlin Heidelberg, Germany
34. Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller, C. (1992) Cell 68, 397-406[Medline] [Order article via Infotrieve]
35. Julià, P., Farrés, J., and Parés, X. (1987) Eur. J. Biochem. 162, 179-189[Abstract]
36. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
37. Frohman, M. A. (1993) Methods Enzymol. 218, 340-356[Medline] [Order article via Infotrieve]
38. Chomczynski, P., and Sauhi, N. (1987) Anal. Biochem. 162, 156-159[CrossRef][Medline] [Order article via Infotrieve]
39. Fernández, M. R., Biosca, J. A., Torres, D., Crosas, B., and Parés, X. (1999) J. Biol. Chem. 274, 37869-37875[Abstract/Free Full Text]
40. Parés, X., and Julià, P. (1990) Methods Enzymol. 189, 436-441[Medline] [Order article via Infotrieve]
41. Wilson, D. K., Bohren, K. M., Gabbay, K. H., and Quiocho, F. A. (1992) Science 257, 458-460
42. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
43. Bennett, M. J., Albert, R. H., Jez, J. M., Ma, H., Penning, T. M., and Lewis, M. (1997) Structure 5, 799-812[Medline] [Order article via Infotrieve]
44. Abagyan, R., and Totrov, M. (1994) J. Mol. Biol. 235, 983-1002[CrossRef][Medline] [Order article via Infotrieve]
45. Pearson, W. R., and Lipman, D. J. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2444-2448[Abstract]
46. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve]
47. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680[Abstract]
48. Page, R. D. (1996) Comput. Appl. Biosci. 12, 357-358[Medline] [Order article via Infotrieve]
49. Estonius, M., Karlsson, C., Fox, E. A., Hoog, J. O., Holmquist, B., Vallee, B. L., Davidson, W. S., and Jörnvall, H. (1990) Eur. J. Biochem. 194, 593-602[Abstract]
50. Tarle, I., Borhani, D. W., Wilson, D. K., Quiocho, F. A., and Petrash, J. M. (1993) J. Biol. Chem. 268, 25687-25693[Abstract/Free Full Text]
51. Wilson, D. K., Nakano, T., Petrash, J. M., and Quiocho, F. A. (1995) Biochemistry 34, 14323-14330[Medline] [Order article via Infotrieve]
52. Ye, Q., Hyndman, D. J., Li, X., Flynn, T. G., and Jia, Z. (2000) Proteins 38, 41-48[CrossRef][Medline] [Order article via Infotrieve]
53. De Winter, H. L., and von Itzstein, M. (1995) Biochemistry 34, 8299-8308[Medline] [Order article via Infotrieve]
54. Petrash, J. M., Harter, T. M., Devine, C. S., Olins, P. O., Bhatnagar, A., Liu, S., and Srivastava, S. K. (1992) J. Biol. Chem. 267, 24833-24840[Abstract/Free Full Text]
55. Várnai, P., Richards, W. G., and Lyne, P. D. (1999) Proteins 37, 218-227[Medline] [Order article via Infotrieve]
56. Julià, P., Farrés, J., and Parés, X. (1986) Exp. Eye Res. 42, 305-314[Medline] [Order article via Infotrieve]
57. Farrés, J., Moreno, A., Crosas, B., Peralba, J. M., Allali-Hassani, A., Hjelmqvist, L., Jörnvall, H., and Parés, X. (1994) Eur. J. Biochem. 224, 549-557[Abstract]
58. Bohren, K. M., Grimshaw, C. E., and Gabbay, K. H. (1992) J. Biol. Chem. 267, 20965-20970[Abstract/Free Full Text]
59. Lefrançois-Martínez, A. M., Tournaire, C., Martínez, A., Berger, M., Daoudal, S., Tritsch, D., Veyssiere, G., and Jean, C. (1999) J. Biol. Chem. 274, 32875-32880[Abstract/Free Full Text]
60. Jörnvall, H., Persson, M., and Jeffery, J. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4226-4230[Abstract]
61. Winberg, J. O., Thatcher, D. R., and McKinley-McKee, J. S. (1982) Biochim. Biophys. Acta 704, 7-16[Medline] [Order article via Infotrieve]
62. Altamirano, M. M., Blackburn, J. M., Aguayo, C., and Fersht, A. R. (2000) Nature 403, 617-622[CrossRef][Medline] [Order article via Infotrieve]
63. Rondeau, J. M., Tete-Favier, F., Podjarny, A., Reymann, J. M., Barth, P., Biellmann, J. F., and Moras, D. (1992) Nature 355, 469-472[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.